Haworth brings extensive animal health expertise to Canine Biologics' board

DENVER, CO, September 30, 2021 /24-7PressRelease/ -- Canine Biologics announced today that David Haworth has been appointed to its Board of Directors.

Dr. Haworth, DVM, Ph.D., brings more than 20 years of experience in the animal health industry. Haworth is the president and co-founder of Vidium Animal Health. He previously served as president of PetSmart Charities in the US and Canada, and CEO of Morris Animal Foundation. Haworth also served as a Director of Global Alliances and Director of Research and Development at Pfizer Animal Health (now Zoetis). He holds DVM and PhD degrees from Colorado State University and completed a postdoctoral fellowship at Colorado State University's Flint Animal Cancer Center. Haworth truly understands the impact this disease can have as his Labrador Retriever, Bridger, is a cancer survivor.

"We are pleased to welcome David to our Board of Directors at this important next stage of Canine Biologics' evolution," stated Jeff Sutherland, Canine Biologics' President and Chief Executive Officer. "As a highly respected and seasoned executive and veterinarian with valuable industry experience, we look forward to David's expert engagement and assistance in guiding our objectives to bring breakthrough cancer nutrition and related products to the market for veterinarians, veterinary oncologists and pet owners alike."

"I am excited about joining the Canine Biologics' Board," Dr. Haworth said. "I look forward to working alongside my fellow Board members and company management to advance truly innovative products that benefit companion animals battling cancer.

About Canine Biologics
Canine Biologics is a nutrition company focused on the development of new and innovative products to support companion animals in their fight against cancer and with certain other critical care needs. Canine Biologics' lead product, its Integrated Nutrition System, is available to pet parents and veterinarians throughout the US with plans to soon be available in Canada and other international markets. Additional products are under development and will be rolled out over the next 12 to 18 months. Additional information about Canine Biologics can be obtained at http://www.caninebiologics.com.

---
Press release service and press release distribution provided by http://www.24-7pressrelease.com